123 related articles for article (PubMed ID: 37966247)
21. Metformin suppresses growth and adrenocorticotrophic hormone secretion in mouse pituitary corticotroph tumor AtT20 cells.
Jin K; Ruan L; Pu J; Zhong A; Wang F; Tan S; Huang H; Mu J; Yang G
Mol Cell Endocrinol; 2018 Dec; 478():53-61. PubMed ID: 30025915
[TBL] [Abstract][Full Text] [Related]
22. Long-Term Outcome of Nonfunctioning and Hormonal Active Pituitary Adenoma After Gamma Knife Radiosurgery.
Narayan V; Mohammed N; Bir SC; Savardekar AR; Patra DP; Bollam P; Nanda A
World Neurosurg; 2018 Jun; 114():e824-e832. PubMed ID: 29574220
[TBL] [Abstract][Full Text] [Related]
23. Gamma knife radiosurgery in patients with Cushing's disease: Comparison of aggressive pituitary corticotroph tumor versus corticotroph adenoma.
Kara M; Güdük M; Samanci Y; Yilmaz M; Şengöz M; Peker S
Clin Neurol Neurosurg; 2020 Oct; 197():106151. PubMed ID: 32882541
[TBL] [Abstract][Full Text] [Related]
24. Whole Sella vs Targeted Stereotactic Radiosurgery for Acromegaly: A Multicenter Matched Cohort Study.
Taylor DG; Janssen A; Ding D; Xu Z; Mehta GU; Liscak R; Kano H; Kosak M; Martinez-Moreno N; Hobbs L; Chen CJ; Grills IS; Mathieu D; Lunsford LD; Vance ML; Sheehan JP
Neurosurgery; 2020 May; 86(5):656-664. PubMed ID: 31384920
[TBL] [Abstract][Full Text] [Related]
25. Why don't corticotroph tumors always produce Cushing's disease?
García-Martínez A; Cano DA; Flores-Martínez A; Gil J; Puig-Domingo M; Webb SM; Soto-Moreno A; Picó A
Eur J Endocrinol; 2019 Sep; 181(3):351-361. PubMed ID: 31319379
[TBL] [Abstract][Full Text] [Related]
26. Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently.
Bradley KJ; Wass JA; Turner HE
Clin Endocrinol (Oxf); 2003 Jan; 58(1):59-64. PubMed ID: 12519413
[TBL] [Abstract][Full Text] [Related]
27. Update on Current Evidence for the Diagnosis and Management of Nonfunctioning Pituitary Neuroendocrine Tumors.
Whyte E; Nezu M; Chik C; Tateno T
Endocrinol Metab (Seoul); 2023 Dec; 38(6):631-654. PubMed ID: 37964483
[TBL] [Abstract][Full Text] [Related]
28. Stereotactic Radiosurgery for Residual and Recurrent Nonfunctioning Pituitary Adenomas: A Contemporary Case Series of GammaKnife and CyberKnife Radiosurgery.
Tucker D; Penn M; Brunswick A; Uttarwar V; Gogia A; Marietta M; Yu C; Carmichael J; Chang E; Zada G
World Neurosurg; 2020 Nov; 143():e60-e69. PubMed ID: 32603864
[TBL] [Abstract][Full Text] [Related]
29. The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution.
Kong DS; Lee JI; Lim DH; Kim KW; Shin HJ; Nam DH; Park K; Kim JH
Cancer; 2007 Aug; 110(4):854-60. PubMed ID: 17599761
[TBL] [Abstract][Full Text] [Related]
30. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
[TBL] [Abstract][Full Text] [Related]
31. The clinicopathological features and prognosis of silent corticotroph tumors: an updated systematic review and meta-analysis.
Vuong HG; Dunn IF
Endocrine; 2023 Dec; 82(3):527-535. PubMed ID: 37462809
[TBL] [Abstract][Full Text] [Related]
32. Hypopituitarism after gamma knife radiosurgery for pituitary adenoma.
Zibar Tomšić K; Dušek T; Kraljević I; Heinrich Z; Solak M; Vučinović A; Ozretić D; Mihailović Marasanov S; Hršak H; Kaštelan D
Endocr Res; 2017 Nov; 42(4):318-324. PubMed ID: 28537768
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
[TBL] [Abstract][Full Text] [Related]
34. Treatment of pituitary adenomas using radiosurgery and radiotherapy: a single center experience and review of literature.
Sun DQ; Cheng JJ; Frazier JL; Batra S; Wand G; Kleinberg LR; Rigamonti D; Quinones-Hinojosa A; Salvatori R; Lim M
Neurosurg Rev; 2010 Apr; 34(2):181-9. PubMed ID: 20838838
[TBL] [Abstract][Full Text] [Related]
35. Clinical features of silent corticotroph adenomas.
Alahmadi H; Lee D; Wilson JR; Hayhurst C; Mete O; Gentili F; Asa SL; Zadeh G
Acta Neurochir (Wien); 2012 Aug; 154(8):1493-8. PubMed ID: 22619024
[TBL] [Abstract][Full Text] [Related]
36. Hypopituitarism after stereotactic radiosurgery for pituitary adenomas.
Xu Z; Lee Vance M; Schlesinger D; Sheehan JP
Neurosurgery; 2013 Apr; 72(4):630-7; 636-7. PubMed ID: 23277375
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic radiosurgery for WHO grade I posterior fossa meningiomas: long-term outcomes with volumetric evaluation.
Patibandla MR; Lee CC; Tata A; Addagada GC; Sheehan JP
J Neurosurg; 2018 Nov; 129(5):1249-1259. PubMed ID: 29303453
[TBL] [Abstract][Full Text] [Related]
38. Gamma knife radiosurgery for patients with nonfunctioning pituitary adenomas: results from a 15-year experience.
Pollock BE; Cochran J; Natt N; Brown PD; Erickson D; Link MJ; Garces YI; Foote RL; Stafford SL; Schomberg PJ
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1325-9. PubMed ID: 18029107
[TBL] [Abstract][Full Text] [Related]
39. Long-term Outcome After Fractionated Radiotherapy for Pituitary Adenoma: The Curse of the Secretory Tumor.
Scheick S; Amdur RJ; Kirwan JM; Morris CG; Mendenhall WM; Roper S; Friedman W
Am J Clin Oncol; 2016 Feb; 39(1):49-54. PubMed ID: 25007040
[TBL] [Abstract][Full Text] [Related]
40. Factors associated with endocrine deficits after stereotactic radiosurgery of pituitary adenomas.
Leenstra JL; Tanaka S; Kline RW; Brown PD; Link MJ; Nippoldt TB; Young WF; Pollock BE
Neurosurgery; 2010 Jul; 67(1):27-32; discussion 32-3. PubMed ID: 20559089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
